Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience.
about
Intra-arterial chemoradiotherapy for head and neck cancerIntensity modulated radiotherapy for sinonasal malignancies with a focus on optic pathway preservationSuperselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer.Contemporary management of sinonasal cancer.Reporting standards for endovascular chemotherapy of head, neck and CNS tumors.Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances.Craniofacial Resection for T4 Maxillary Sinus Carcinoma: Managing Cases with Involvement of the Skull Base.Osteoradionecrosis of the hyoid bone after intra-arterial chemoradiotherapy for oropharyngeal cancer: MR imaging findings.Radiotherapy in late elderly (aged 75 or older) patients with paranasal sinus carcinoma: a single institution experience.Cerebral infarction after intraarterial and intravenous chemoradiotherapy for head and neck cancer: A retrospective analysis using a Japanese inpatient database.Organ preservation with neoadjuvant chemoradiation in patients with orbit invasive sinonasal cancer otherwise requiring exenteration.Comment on 'Impact of intra-arterial chemotherapy including internal carotid artery for advanced paranasal sinus cancers involving the skull base'.Effect of local extension sites on survival in locally advanced maxillary sinus cancer.Experiments for the Development of a Steerable Microcatheter.ACR appropriateness criteria® nasal cavity and paranasal sinus cancers.Usefulness of Pseudocontinuous Arterial Spin-Labeling for the Assessment of Patients with Head and Neck Squamous Cell Carcinoma by Measuring Tumor Blood Flow in the Pretreatment and Early Treatment Period.Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose-finding phase.Prediction of the treatment outcome using intravoxel incoherent motion and diffusional kurtosis imaging in nasal or sinonasal squamous cell carcinoma patients.Preliminary results of proton beam therapy combined with weekly cisplatin intra-arterial infusion via a superficial temporal artery for treatment of maxillary sinus carcinoma.Evaluation of nodal response after intra-arterial chemoradiation for node-positive head and neck cancer.Semi-quantitative analysis of pre-treatment morphological and intratumoral characteristics using F-fluorodeoxyglucose positron-emission tomography as predictors of treatment outcome in nasal and paranasal squamous cell carcinoma
P2860
Q26781184-65FE4408-D614-4AA0-904B-F9413FE1172AQ27027499-039C605E-A070-4E76-AD74-AD542937A139Q37385259-3B74F03A-00B6-4EF7-98FD-DD0408613167Q37782308-BC203C82-11FF-4FF7-965F-D130B497908AQ38119427-9C57D055-A83E-478E-9350-36C434094860Q38220715-83DC39AC-B81F-4A1C-85F5-78C5D747759CQ38516502-13609D62-EE9D-4229-89C0-F2F5BCAC0A83Q40116705-B665939F-7BFD-4C98-8B75-9C3CA5881698Q40695276-9DD45148-7E3B-4A04-9C6C-84274F7E7BCEQ40832963-7668E859-9FEB-4B35-92AD-C23FDBB02277Q41475918-B7C6957B-EDDD-40F0-88C9-DFA59DC0D32EQ43099403-2A9BF417-B006-47E2-8064-745479C4BD7EQ45417076-514D2A41-3BF6-490E-834F-CBE6EA74202DQ47707148-6991F141-EEC4-4AEB-A92F-32B4A7739D3AQ48109224-6874A11A-3AE2-4B8A-BFDB-6FDD0C9517F8Q48125617-9B8EAE22-A131-4A9D-9942-DB2017B5BCD7Q48318260-4FE6837B-6CCF-48C7-B46A-E53752039653Q51306915-6D653712-8400-41B2-A926-C1C4C7E30ABDQ52147148-A2FD750B-EA14-4544-B8AE-3A61CB63952DQ53193995-93FAC563-EA12-413F-B85E-CBD445EC28FBQ57300755-677C6F85-81F3-4EDA-AE7E-56A2EBBD21DC
P2860
Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Superselective high-dose cispl ...... single institution experience.
@en
Superselective high-dose cispl ...... single institution experience.
@nl
type
label
Superselective high-dose cispl ...... single institution experience.
@en
Superselective high-dose cispl ...... single institution experience.
@nl
prefLabel
Superselective high-dose cispl ...... single institution experience.
@en
Superselective high-dose cispl ...... single institution experience.
@nl
P2093
P356
P1433
P1476
Superselective high-dose cispl ...... single institution experience.
@en
P2093
Akihiro Homma
Daisuke Yoshida
Fumiyuki Suzuki
Hiroki Shirato
Nobuhiko Oridate
Satoshi Fukuda
Shigenari Taki
Takeshi Asano
Takeshi Nishioka
P2860
P304
P356
10.1002/CNCR.24515
P407
P577
2009-10-01T00:00:00Z